DO
Duo Oncology Inc.
SEC filingPharmaceuticals · Pittsburgh, PA
Amount raised$1.6Msold at filing
Total offering$3.5M$1.9M still open
Investors in the raise13count reported to the SEC
FiledAug 7, 2026first sale Jun 2, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
JING-ZHOU HOUExecutive Officer, Director, Promoter
SAM ROTHSTEINExecutive Officer, Director, Promoter
STEPHEN THORNEExecutive Officer, Promoter
VICTORIA MANAXDirector
STANLEY MARKSDirector
SONG LIDirector, Promoter
KATHERINE EICHINGERExecutive Officer
JOE GATTODirector
LUSONG LUODirector
Executive officers, directors and promoters as listed on the Form D.